384 related articles for article (PubMed ID: 2818723)
1. The effects of calcium and magnesium in hyperkalemic cardioplegic solutions on myocardial preservation.
Geffin GA; Love TR; Hendren WG; Torchiana DF; Titus JS; Redonnett BE; O'Keefe DD; Daggett WM
J Thorac Cardiovasc Surg; 1989 Aug; 98(2):239-50. PubMed ID: 2818723
[TBL] [Abstract][Full Text] [Related]
2. Calcium-induced ventricular contraction during cardioplegic arrest.
Torchiana DF; Love TR; Hendren WG; Geffin GA; Titus JS; Redonnett BE; O'Keefe DD; Daggett WM
J Thorac Cardiovasc Surg; 1987 Oct; 94(4):606-13. PubMed ID: 3657262
[TBL] [Abstract][Full Text] [Related]
3. Oxygenation of cardioplegic solutions. Potential for the calcium paradox.
Hendren WG; Geffin GA; Love TR; Titus JS; Redonnett BE; O'Keefe DD; Daggett WM
J Thorac Cardiovasc Surg; 1987 Oct; 94(4):614-25. PubMed ID: 3116349
[TBL] [Abstract][Full Text] [Related]
4. Optimal myocardial preservation with an acalcemic crystalloid cardioplegic solution.
Boggs BR; Torchiana DF; Geffin GA; Titus JS; Redonnett BE; O'Keefe DD; Newell JB; Daggett WM
J Thorac Cardiovasc Surg; 1987 Jun; 93(6):838-46. PubMed ID: 3573797
[TBL] [Abstract][Full Text] [Related]
5. The effects of Ca++ on the preservation of myocardial energy and function with University of Wisconsin solution. A 31P nuclear magnetic resonance study of isolated blood perfused Langendorff pig hearts.
Tian G; Biro GP; Butler KW; Xiang B; Vu C; Deslauriers R
J Heart Lung Transplant; 1993; 12(1 Pt 1):81-8. PubMed ID: 8443206
[TBL] [Abstract][Full Text] [Related]
6. Normocalcemic blood or crystalloid cardioplegia provides better neonatal myocardial protection than does low-calcium cardioplegia.
Pearl JM; Laks H; Drinkwater DC; Meneshian A; Sun B; Gates RN; Chang P
J Thorac Cardiovasc Surg; 1993 Feb; 105(2):201-6. PubMed ID: 8429645
[TBL] [Abstract][Full Text] [Related]
7. Relation of myocardial protection to cardioplegic solution pH: modulation by calcium and magnesium.
Geffin GA; Reynolds TR; Titus JS; O'Keefe DD; Daggett WM
Ann Thorac Surg; 1991 Oct; 52(4):955-64. PubMed ID: 1929661
[TBL] [Abstract][Full Text] [Related]
8. The immature and the mature myocardium. Responses to multidose crystalloid cardioplegia.
Magovern JA; Pae WE; Miller CA; Waldhausen JA
J Thorac Cardiovasc Surg; 1988 Apr; 95(4):618-24. PubMed ID: 3352295
[TBL] [Abstract][Full Text] [Related]
9. Continuous warm versus intermittent cold cardioplegic infusion: a comparison of energy metabolism, sodium-potassium adenosine triphosphatase activity, and postischemic functional recovery in the blood-perfused rat heart.
Qiu Y; Galiñanes M; Haddock PS; Hcarse DJ
J Thorac Cardiovasc Surg; 1996 Sep; 112(3):797-805. PubMed ID: 8800170
[TBL] [Abstract][Full Text] [Related]
10. Influence of preconditioning on rat heart subjected to prolonged cardioplegic arrest.
Ogino H; Smolenski RT; Zych M; Seymour AM; Yacoub MH
Ann Thorac Surg; 1996 Aug; 62(2):469-74. PubMed ID: 8694607
[TBL] [Abstract][Full Text] [Related]
11. Oxygen requirements of the isolated rat heart during hypothermic cardioplegia. Effect of oxygenation on metabolic and functional recovery after five hours of arrest.
de Wit L; Coetzee A; Kotze J; Lochner A
J Thorac Cardiovasc Surg; 1988 Feb; 95(2):310-20. PubMed ID: 3339898
[TBL] [Abstract][Full Text] [Related]
12. Maintenance of the myocardial thiol pool by N-acetylcysteine. An effective means of improving cardioplegic protection.
Menasché P; Grousset C; Gauduel Y; Mouas C; Piwnica A
J Thorac Cardiovasc Surg; 1992 May; 103(5):936-44. PubMed ID: 1569775
[TBL] [Abstract][Full Text] [Related]
13. Long-term preservation of explanted hearts perfused with L-aspartate-enriched cardioplegic solution. Improved function, metabolism, and ultrastructure.
Choong YS; Gavin JB; Buckman J
J Thorac Cardiovasc Surg; 1992 Feb; 103(2):210-8. PubMed ID: 1735986
[TBL] [Abstract][Full Text] [Related]
14. Heart preservation: analysis of cardioprotective infusate characteristics. Membrane stabilization, calcium antagonism, and protease inhibition on myocardial viability: a biochemical, ultrastructural, functional study.
Sultan I; Sunamori M; Suzuki A
J Heart Lung Transplant; 1992; 11(4 Pt 1):607-18. PubMed ID: 1379828
[TBL] [Abstract][Full Text] [Related]
15. Myocardial preservation related to magnesium content of hyperkalemic cardioplegic solutions at 8 degrees C.
Reynolds TR; Geffin GA; Titus JS; O'Keefe DD; Daggett WM
Ann Thorac Surg; 1989 Jun; 47(6):907-13. PubMed ID: 2757448
[TBL] [Abstract][Full Text] [Related]
16. Protection of the hypertrophied pig myocardium. A comparison of crystalloid, blood, and Fluosol-DA cardioplegia during prolonged aortic clamping.
Novick RJ; Stefaniszyn HJ; Michel RP; Burdon FD; Salerno TA
J Thorac Cardiovasc Surg; 1985 Apr; 89(4):547-66. PubMed ID: 3157028
[TBL] [Abstract][Full Text] [Related]
17. L-aspartate improves the functional recovery of explanted hearts stored in St. Thomas' Hospital cardioplegic solution at 4 degrees C.
Choong YS; Gavin JB
J Thorac Cardiovasc Surg; 1990 Mar; 99(3):510-7. PubMed ID: 2308369
[TBL] [Abstract][Full Text] [Related]
18. Protection of the immature myocardium during ischemic arrest: dose dependent effects of glucose and mannitol when added to St Thomas' cardioplegic solution.
Yang SS; Hearse DJ
Can J Cardiol; 1989; 5(8):401-7. PubMed ID: 2514036
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of myocardial protective effects between GIK solution and St. Thomas solution by use of canine isolated heart-lung preparations].
Ina H; Yasuda I
Nihon Kyobu Geka Gakkai Zasshi; 1989 Nov; 37(11):2318-27. PubMed ID: 2693545
[TBL] [Abstract][Full Text] [Related]
20. Myocardial protection: the efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent.
Bessho R; Chambers DJ
J Thorac Cardiovasc Surg; 2001 Nov; 122(5):993-1003. PubMed ID: 11689806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
